Source:http://linkedlifedata.com/resource/pubmed/id/17430172
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2007-4-13
|
pubmed:abstractText |
NAP (Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln, single letter code: NAPVSIPQ) and ADNF-9 (activity-dependent neurotrophic factor-9; Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala; single letter code: SALLRSIPA) are peptides derived from naturally occurring glial proteins that have shown neuroprotection in rodent model systems. Here, the neuroprotective activity of ADNF-9 and NAP was tested in two human models of neuronal degeneration in culture mediated by oxidative stress: normal human cortical neurons treated with H2O2 and Down's syndrome (DS) cortical neurons. Incubation of normal cortical neurons with 50 microM H2O2 for 1 hour resulted in morphological and structural changes consistent with neuronal degeneration and loss of viability of more than 60% of the neurons present in the culture. Addition of ADNF-9 or NAP at femtomolar concentrations resulted in significant increases in survival of normal neurons treated with H2O2. Femtomolar concentrations of ADNF-9 or NAP exhibited a similar neuroprotective efficacy, comparable to the antioxidant N-tert-butyl-2-sulpho-phenylnitrone at 100 microM (s-PBN). Treatment of DS cortical neurons with ADNF-9 or NAP resulted in a significant increase in neuronal survival as well as reduction of degenerative morphological changes. The results suggest that ADNF-9 and NAP possess potent neuroprotective properties against oxidative damage in human neurons that may be useful to preserve neuronal function and prevent neuronal death associated with chronic neurodegenerative disorders.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1873-4286
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1091-8
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading |
pubmed-meshheading:17430172-Animals,
pubmed-meshheading:17430172-Apoptosis,
pubmed-meshheading:17430172-Cell Survival,
pubmed-meshheading:17430172-Cells, Cultured,
pubmed-meshheading:17430172-Cerebral Cortex,
pubmed-meshheading:17430172-Down Syndrome,
pubmed-meshheading:17430172-Fetus,
pubmed-meshheading:17430172-Humans,
pubmed-meshheading:17430172-Mice,
pubmed-meshheading:17430172-Neurodegenerative Diseases,
pubmed-meshheading:17430172-Neurons,
pubmed-meshheading:17430172-Neuroprotective Agents,
pubmed-meshheading:17430172-Oligopeptides,
pubmed-meshheading:17430172-Oxidative Stress
|
pubmed:year |
2007
|
pubmed:articleTitle |
NAP and ADNF-9 protect normal and Down's syndrome cortical neurons from oxidative damage and apoptosis.
|
pubmed:affiliation |
Department of Neurobiology and Behavior, University of California, Irvine, CA 92697, USA. jbuscigl@uci.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|